Evaluation of Subcutaneous Immunotherapy Towards Pollen in Children
Status:
Active, not recruiting
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
The objective is to prospectively explore associations between immunological parameters in
blood and clinical effect of subcutaneous immunotherapy (SCIT) in children with severe
allergy towards pollen. Half of the children will receive SCIT while the other half will
start SCIT after the study is finished. Clinical evaluations of symptoms and an immunological
survey will be performed before start of SCIT and after one year of treatment. Some of the
immunological parameters will also be checked after 6 months of treatment